Gland Pharma Ltd is an Indian Pharmaceutical company. It was established in 1978, at Hyderabad, India. The founder is PVN Raju. It has
Gland Pharma Ltd Research Tear Sheet Q1 FY 23
Categories
pharmaceuticals
Biocon Limited (BIOCON) Q1 FY23 Earnings Concall Transcript
Biocon Limited (NSE : BIOCON) Q1 FY23 Earnings Concall dated July. 27, 2022 Corporate Participants: Kiran Mazumdar Shaw -- Executive Chairperson Biocon Limited and
Gland Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/wKPiFWdsaFY Key highlights from Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Management Update: GLAND said it is experiencing increased attrition and
Cipla Q4 FY2022 Research Summary
Cipla is an Indian multinational pharmaceutical company. The company was incorporated in the year 1935. The founder is Khwaja Abdul Hamied. Cipla
Sun Pharmaceuticals Industries Ltd. Q4 FY 2022 Research Summary
Overview Sun Pharmaceutical Industries Limited is an Indian pharmaceutical company. The headquarters is situated in Mumbai, Maharashtra. It was incorporated in 1983.
IOL Chemicals and Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/HCB5WuVf8_E Key highlights from IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q4 FY22 Earnings Concall Management Update: IOLCP is optimistic on its
Marksans Pharma Limited Q4 FY22 Earnings Conference Call Insights
Key highlights from Marksans Pharma Limited (MARKSANS) Q4 FY22 Earnings Concall Q&A Highlights: Vijay Nahar - Individual Investor - Analyst Challenges
Lupin Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall Q&A Highlights: Pritesh Vora - Mission Street India - Analyst
SMS Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from SMS Pharmaceuticals Ltd (SMSPHARMA) Q4 FY22 Earnings Concall Management Update: SMSPHARMA said its near-term focus remains on scaling up
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q4 FY22 Earnings Concall dated May. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief Financial
Aurobindo Pharma Q4 FY 2022 Research Tear Sheet
Aurobindo Pharma Limited is an Indian pharmaceutical company. It was established in the year 1986. The founders include Mr. P.V. Ramprasad Reddy,
Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/ZZNGEHlRimc Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3 ANDAs and
Hikal Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/3z2q_SR1OS4 Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in anti-diabetic have
Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights
https://youtu.be/uTUQ9VpSoiU Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to significantly
Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript
Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer
Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire to achieve
Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about Brazil market,
Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/VIL70Aj2g04 Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the company’s focus
Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue for FY22
Dr. Reddy’s Laboratories (DRREDDY) Q4 FY22 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE: DRREDDY) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations G V
Gland Pharma Ltd. (GLAND) Q4 FY22 Earnings Concall Transcript
Gland Pharma Ltd. (NSE: GLAND) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President-Finance & Investor Relations Srinivas